Sustainability Life sciences faces a battle with sustainability, but let’s ... We know that the global healthcare sector is a contributor to the warming of our planet.
Views & Analysis Increasing sustainability in pharma requires an industry-wid... With COP27 concluding in November, Ben Hargreaves takes a look at what efforts pharma companies are making to limit their environmental impact.
News Supporting the era of green pharmaceuticals in the UK According to a report by the Office of Health Economics (OHE), commissioned by the Association of th
Views & Analysis It’s time get real with healthcare's commitment to net zero Every fraction of a degree matters
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
